Calculation of the glucose metabolic rate (MRGIc) in brain with PET and 2-[18F] fluoro-2-
deoxy-D-glucose(FDG) requires knowing the rate of uptake of FDG relative to glucose from …

Quantitative imaging of glucose metabolism of human brain tumors with PET utilizes 2-[18F]-
fluorodeoxy-D-glucose (FDG) and a conversion factor called the lumped constant (LC) …

The rate constants K* 1and k* 2refer to forward and reverse capillary trans port of FDG, while
k* 3 and k* 4 refer to phosphorylation of FDG and de phosphorylation of FDG-6-P04, re …

Twenty-six patients with gliomas of WHO-grades two to four were examined with dynamic
positron emission tomography (PET) and 18 F-2-fluoro-2-deoxy-D-glucose (FDG). FDG rate …

gests intrinsic metabolic differences between untreated tumors and tumors recurringafter
therapy, in which high LCMRG1 values have been observed (2, 4, 42). ― All of these three …

Positron emission tomography was used to measure local cerebral glucose utilization by the
2-[18F] fluoro-2-deoxy-D-glucose technique in 23 patients with cerebral gliomas. All 10 high …

The enhanced rate of glucose utilization by tumor cells has been exploited in the imaging of
tumors using the radiolabelled glucose analogue fluoro-2-deoxy-D-glucose (FDG)[1], which …

[en] The predominance of the nonoxidative over the more efficient oxidative metabolic
pathway results in a higher glucose utilization rate in high-grade than in low-grade tumor …

Abstract Tumor uptake of [18 F] 2-fluoro-2-deoxy-glucose (FDG) was studied in 20 patients
with histologically classified gliomas, using dynamic positron emission tomography (PET) …

MATERIALSAND METhODS Subjects A totalof ten patients, seven malesandthreefemales,
mean age46. 3yr (range29to70yr), werestudied. Theyincludedeight gliomas, one metastatic …